EU Pharma Industry Warns of Costly Exodus to Lower-Cost Jurisdictions as US Tariff Threats Loom
European pharmaceutical companies are sounding the alarm over the potential relocation of operations to the United States due to looming tariffs on the sector, as warned by US President Donald Trump. At a crucial meeting with European Commission President Ursula von der Leyen, the European Federation of Pharmaceutical Industries and Associations (EFPIA) highlighted the risk […]
Continue Reading